<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>ACE inhibitor improves survival in moderate HF</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">ACE inhibitor improves survival in moderate HF</h1>
<div class="graphic"><div class="figure"><div class="ttl">ACE inhibitor improves survival in moderate HF</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Enalapril, compared with placebo, decreases patient mortality in NYHA classes II and III heart failure (p = 0.0036).</div><div class="graphic_footnotes">ACE: angiotensin-converting enzyme; HF: heart failure; NYHA: New York Heart Association.Â </div><div class="graphic_reference">Data from: The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325:293.</div><div id="graphicVersion">Graphic 70015 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
